The US Food and Drug Administration has created a new advisory committee to better inform the agency on “the complex, scientific and technical issues” related to digital health technologies (DHTs).
The Digital Health Advisory Committee will advise the agency on such matters as artificial intelligence/machine learning (AI/ML), augmented reality, virtual reality, digital therapeutics, wearables, remote
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?